In Brief: DHEA
This article was originally published in The Tan Sheet
Executive Summary
DHEA: The adrenal androgen supplement is featured in the Oct. 11 issue of The Medical Letter -- the weekly publication for medical professionals distills current data on drugs and other products to help professionals respond to patient questions and keep abreast of side-effect profiles, adverse events and efficacy. The Medical Letter concludes that there is "no convincing evidence that DHEA has any beneficial effect on aging or any disease." DHEA "can have androgenic adverse effects in women, including some that may be irreversible. In men," the publication states, DHEA "could stimulate the growth of prostate cancer....Patients would be well advised not to take it"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning